Delivery Order SPE2DE23D0008-SPE2D625F3XKZ
Award Date 9/19/25
Potential Completion Date 9/23/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814 fixed-price delivery order for Natrelle Inspira SCM 330cc breast implants by the Defense Logistics Agency (DLA) Troop Support Medical on September 5, 2025. This delivery order, which has no set-aside designation, is a child contract stemming from one of Allergan's larger Indefinite Delivery Vehicles—specifically the $13.5 million Natrelle breast implants and surgical devices IDV established on December 8, 2022. The order is...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $1,425.00 for Natrelle Inspira SCM 560CC breast implants by the Defense Logistics Agency Medical Supply Chain, a Defense agency division. The award, issued on August 14, 2025, represents a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of August 18, 2025. The contract was awarded without set-aside designation, reflecting Allergan's status as a...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $5,421.00 fixed-price delivery order contract by the Defense Logistics Agency Medical Supply Chain on July 21, 2025, for Natrelle Inspira SSM 210CC breast implants. The contract, which carries an ultimate completion date of July 23, 2025, will be performed at Allergan's facility in Irvine, California. This delivery order was awarded without set-aside designation, reflecting Allergan's status as the sole-source provider of these...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a $2,814 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 16, 2025, for Natrelle Inspira SCF 605CC breast implants. This delivery order, with an ultimate completion date of September 18, 2025, represents a child contract issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical devices to federal healthcare systems. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order on September 11, 2025, for Natrelle Inspira SCX 495CC breast implants, with a completion date of September 15, 2025. The contract was awarded without a set-aside designation and is being performed in Irvine, California. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain division, which oversees procurement of specialized medical devices for the Department of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,092.00 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division for Inspira SRLP 205CC breast implants. The award, made on September 11, 2025, with an ultimate completion date of September 22, 2025, represents a child delivery order under one of Allergan's larger Indefinite Delivery Vehicle contracts for Natrelle breast implants and surgical devices valued at $13.5 million. The contract utilizes...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $1,200 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SSF 325CC breast implants. This delivery order, awarded on July 24, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle (IDV) agreements. The contract does not utilize a set-aside designation, reflecting Allergan's position...
- The U.S. Department of Defense Medical Supply Chain division awarded a $2,814.00 fixed-price delivery order to Allergan USA Inc. (a subsidiary of AbbVie Inc.) on May 30, 2025, for Natrelle Inspira SCF 385CC breast implants with an ultimate completion date of May 30, 2025. The delivery order will be performed in Irvine, California, and includes economic price adjustment provisions. This award was made without a set-aside designation, reflecting Allergan's status as the sole source for this...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a $9,109 fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical on June 26, 2025, for Natrelle TE Smooth 133S-MV-11-T breast implants. This delivery order, which carries no set-aside designation, is scheduled for completion by June 30, 2025, with performance to be executed in Irvine, California. The award represents a child contract action under one of Allergan's two significant Indefinite Delivery...